Neos Therapeutics - Ownership and Business Overview

Life ScienceCompany

Neos Therapeutics Ownership

Who owns Neos Therapeutics?

Neos Therapeutics is owned by PDL BioPharma. It was acquired on October 26, 2017.

Neos Therapeutics Business Overview

Where is Neos Therapeutics headquartered?

Neos Therapeutics is headquartered in Grand Prairie, Texas.

What sector is Neos Therapeutics in?

Neos Therapeutics is a life science company.

When was Neos Therapeutics founded?

Neos Therapeutics was founded in 2008.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.

Neos Therapeutics, Inc.

2940 N. Hwy 360 Suite 400,
Grand Prairie, Texas 75050
United Kingdom,
(972) 408-1300
www.neostx.com

Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Adzenys XR-ODT® (amphetamine) extended-release orally disintegrating tablets including Boxed WARNING), Cotempla XR-ODT™ (methylphenidate) extended-release orally disintegrating tablets including Boxed WARNING), and Adzenys-ER™ (amphetamine) extended-release oral suspension including Boxed WARNING), all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform.


 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.